Yakult Honsha Co.,Ltd.

Equities

2267

JP3931600005

Food Processing

Delayed Japan Exchange 10:30:00 2024-04-18 pm EDT 5-day change 1st Jan Change
2,960 JPY -1.37% Intraday chart for Yakult Honsha Co.,Ltd. +0.24% -6.54%

This article is for Premium subscribers only

Signed up already?

Log In

Not subscribed yet?

Subscribe
Tranche Update on Yakult Honsha Co.,Ltd.'s Equity Buyback Plan announced on November 14, 2023. CI
Yakult Honsha Co.,Ltd's Equity Buyback announced on November 14, 2023, has closed with CI
New entry in MarketScreener's Asia portfolio Our Logo
Tranche Update on Yakult Honsha Co.,Ltd.'s Equity Buyback Plan announced on November 14, 2023. CI
Yakult Honsha Co.,Ltd. announces an Equity Buyback for 12,000,000 shares, representing 3.84% for ¥30,000 million. CI
Yakult Honsha Co.,Ltd. authorizes a Buyback Plan. CI
Yakult Honsha Co.,Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Yakult Honsha Co.,Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Nikkei hobbled by absence of catalysts, Wall Street slump RE
Tranche Update on Yakult Honsha Co.,Ltd.'s Equity Buyback Plan announced on February 10, 2022. CI
Yakult Honsha Co.,Ltd.'s Equity Buyback announced on February 10, 2022, has closed with 4,498,000 shares, representing 2.82% for ¥29,999.7 million. CI
Tranche Update on Yakult Honsha Co.,Ltd.'s Equity Buyback Plan announced on February 10, 2022. CI
Tranche Update on Yakult Honsha Co.,Ltd.'s Equity Buyback Plan announced on February 10, 2022. CI
Yakult Honsha Co.,Ltd. announces an Equity Buyback for 5,500,000 shares, representing 3.43% for ¥30,000 million. CI
Yakult Honsha Co.,Ltd. authorizes a Buyback Plan. CI
Japanese shares gain on bargain hunting after sharp losses RE
Japan shares end flat as economic uncertainty around U.S. stimulus weighs RE
Japanese shares dip as U.S. stimulus halt revives economic uncertainty RE
Danone Plans to Sell Shares in Yakult CI
Nestle S A : Danone to sell remaining 500 million euro stake in Japan's Yakult RE
Danone Probiotics Withdraws Shareholder Proposal to Yakult Honsha CI
Verastem, Inc Announces Its Partner Yakult Honsha Co., Ltd Has Dosed the First Patient in A Phase 1B Japanese Bridging Study Evaluating Copiktra CI
The Chiba Kogyo Bank, Ltd. announced that it has received ¥32.65 billion in funding from a group of investors CI
The Chiba Kogyo Bank, Ltd. announced that it expects to receive ¥32.65 billion in funding from a group of investors CI
Yakult Honsha Co.,Ltd Announces Consolidated and Non-Consolidated Earnings Results for the Second Quarter Ended September 30, 2018; Provides Consolidated and Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2019 CI
Chart Yakult Honsha Co.,Ltd.
More charts
YAKULT HONSHA CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of dairy products and pharmaceuticals. The Company operates in three business segments. The Beverages and Food Manufacturing and Sale segment is engaged in the manufacture and sale of dairy products, beverages, noodles and healthy food, the purchase and sale of materials, as well as the transportation business. The Company operates business in Japan, the Americas, Europe, Asia and Oceania. The Pharmaceuticals Manufacturing and Sale segment is engaged in the manufacture and sale of anticancer drugs and other ethical drugs. The Others segment is engaged in the production and sale of cosmetics, as well as the operation of professional baseball clubs.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
3,001 JPY
Average target price
3,529 JPY
Spread / Average Target
+17.59%
Consensus
  1. Stock Market
  2. Equities
  3. 2267 Stock
  4. News Yakult Honsha Co.,Ltd.
  5. Yakult Honsha Co.,Ltd. : A Japanese group with a cult drink